Free Trial

Broadcom (AVGO) Dividend Yield, Date & History

$170.66
+3.19 (+1.90%)
(As of 10/2/2024 ET)

Dividend Summary

Dividend Yield
1.24%
Annual Dividend
$2.12
Dividend Increase
Track Record
15 Years
Annualized 3-Year
Dividend Growth
12.58%
Dividend Payout Ratio
9.12%
Recent
Dividend Payment
Sep. 30
Skip Charts & View Dividend History

Broadcom vs. The Competition

TypeBroadcomComputer CompaniesNASDAQ Companies
Annual Dividend$2.12$3.36$1.24
Dividend Yield1.24%270.41%410.33%
Annualized 3-Year Dividend Growth12.58%12.62%14.32%
Track Record15 years16 years17 years

Broadcom Dividend Payout Ratio

TypePayout Ratio
Based on Trailing 12 Months of Earnings9.12%
Based on This Year's Estimates56.08%
Based on Next Year's Estimates41.41%
Based on Cashflow48.75%

Broadcom Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
9/5/2024quarterly$0.531.39%9/19/20249/19/20249/30/2024
6/12/2024quarterly$0.52501.4%6/24/20246/24/20246/28/2024
3/6/2024quarterly$0.52501.49%3/20/20243/21/20243/29/2024
12/7/2023quarterly$0.52502.28%12/19/202312/20/202312/29/2023
8/30/2023quarterly$0.461.99%9/20/20239/21/20239/29/2023
5/31/2023quarterly$0.462.33%6/21/20236/22/20236/30/2023
Revolutionary Tech Alert: How Elon Musk is Changing Lives (Ad)

"Elon Musk's Neuralink just received FDA breakthrough status for a revolutionary device designed to restore vision to those who've lost it entirely. And the first human clinical trials have opened for recruitment.

3/2/2023quarterly$0.463.07%3/21/20233/22/20233/31/2023
12/8/2022quarterly$0.463.46%12/19/202212/20/202212/30/2022
9/1/2022Quarterly$0.413.28%9/21/20229/22/20229/30/2022
5/26/2022quarterly$0.413.08%6/21/20226/22/20226/30/2022
3/3/2022quarterly$0.412.83%3/21/20223/22/20223/31/2022
12/9/2021quarterly$0.412.66%12/21/202112/22/202112/31/2021
9/2/2021quarterly$0.362.95%9/21/20219/22/20219/30/2021
6/3/2021quarterly$0.363.1%6/21/20216/22/20216/30/2021
3/4/2021quarterly$0.363.23%3/19/20213/22/20213/31/2021
12/10/2020quarterly$0.363.53%12/18/202012/21/202012/31/2020
9/3/2020quarterly$0.32503.63%9/21/20209/22/20209/30/2020
6/4/2020quarterly$0.32504.21%6/19/20206/22/20206/30/2020
3/12/2020quarterly$0.32505.94%3/20/20203/23/20203/31/2020
12/12/2019quarterly$0.32503.97%12/20/201912/23/201912/31/2019
9/12/2019quarterly$0.26503.53%9/20/20199/23/201910/1/2019
6/13/2019quarterly$0.26503.76%6/21/20196/24/20197/2/2019
3/14/2019quarterly$0.26503.95%3/20/20193/21/20193/29/2019
12/6/2018quarterly$0.26504.66%12/18/201812/19/201812/28/2018
9/6/2018quarterly$0.17503.24%9/18/20189/19/20189/28/2018
6/7/2018quarterly$0.17502.64%6/19/20186/20/20186/29/2018
3/15/2018Quarterly$0.17503/21/20183/22/20183/29/2018
12/4/2017Quarterly$0.175012/18/201712/19/201712/29/2017
8/30/2017Quarterly$0.10201.62%9/18/20179/19/20179/29/2017
6/2/2017Quarterly$0.10201.71%6/15/20176/19/20176/30/2017
3/2/2017Quarterly$0.10201.87%3/16/20173/20/20173/31/2017
12/8/2016Quarterly$0.102012/14/201612/16/201612/30/2016
9/2/2016Quarterly$0.05109/15/20169/19/20169/30/2016
6/3/2016Quarterly$0.051.25%6/15/20166/17/20166/30/2016
3/7/2016quarterly$0.04901.34%3/16/20163/18/20163/31/2016
12/8/2015Quarterly$0.04401.19%12/16/201512/18/201512/30/2015
9/4/2015quarterly$0.04201.39%9/16/20159/18/20159/30/2015
6/4/2015$0.046/17/20156/19/20156/30/2015
3/9/2015quarterly$0.03801.2%3/18/20153/20/20153/31/2015
12/9/2014$0.035012/17/201412/19/201412/31/2014
Revolutionary Tech Alert: How Elon Musk is Changing Lives (Ad)

"Elon Musk's Neuralink just received FDA breakthrough status for a revolutionary device designed to restore vision to those who've lost it entirely. And the first human clinical trials have opened for recruitment.

9/4/2014$0.03209/17/20149/19/20149/30/2014
6/6/2014quarterly$0.02901.62%6/17/20146/19/20146/30/2014
3/7/2014quarterly$0.02701.72%3/18/20143/20/20143/31/2014
12/11/2013$0.025012/18/201312/20/201312/31/2013
12/13/2013quarterly$0.02502.19%12/18/201312/20/201312/31/2013
9/6/2013quarterly$0.02302.39%9/17/20139/19/20139/30/2013
6/7/2013quarterly$0.02102.25%6/13/20136/17/20136/28/2013
3/21/2013quarterly$0.01902.14%3/21/20133/25/20134/4/2013
(Data available from 1/1/2013 forward)

Broadcom Dividend - Frequently Asked Questions

What is Broadcom's dividend yield?

The current dividend yield for Broadcom is 1.24%. Learn more on AVGO's dividend yield history.

How much is Broadcom's annual dividend?

The annual dividend for AVGO shares is $2.12. Learn more on AVGO's annual dividend history.

How often does Broadcom pay dividends?

Broadcom pays quarterly dividends to shareholders.

When was Broadcom's most recent dividend payment?

Broadcom's most recent quarterly dividend payment of $0.53 per share was made to shareholders on Monday, September 30, 2024.

When was Broadcom's most recent ex-dividend date?

Broadcom's most recent ex-dividend date was Thursday, September 19, 2024.

Is Broadcom's dividend growing?

Over the past three years, the company's dividend has grown by an average of 12.58% per year.

What track record does Broadcom have of raising its dividend?

Broadcom has increased its dividend for the past 15 consecutive years.

When did Broadcom last increase or decrease its dividend?

The most recent change in the company's dividend was an increase of $0.0050 on Thursday, September 5, 2024.

What is Broadcom's dividend payout ratio?
The dividend payout ratio for AVGO is:
  • 9.12% based on the trailing year of earnings
  • 56.08% based on this year's estimates
  • 41.41% based on next year's estimates
  • 48.75% based on cash flow
Is Broadcom a good dividend stock?

Broadcom's dividend yield of 1.23% is lower than the average Computer and Technology company that issues a dividend. The company's 15 consecutive years of dividend growth indicate that the company has a strong committment to maintain and grow its dividend. Broadcom's dividend payout ratio of 9.12% is at a healthy, sustainable level, below 75% of its earnings.


This page (NASDAQ:AVGO) was last updated on 10/3/2024 by MarketBeat.com Staff
From Our Partners